These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. ITGB2-ICAM1 axis promotes liver metastasis in BAP1-mutated uveal melanoma with retained hypoxia and ECM signatures. Li J; Cao D; Jiang L; Zheng Y; Shao S; Zhuang A; Xiang D Cell Oncol (Dordr); 2024 Jun; 47(3):951-965. PubMed ID: 38150154 [TBL] [Abstract][Full Text] [Related]
9. Transposase mapping identifies the genomic targets of BAP1 in uveal melanoma. Yen M; Qi Z; Chen X; Cooper JA; Mitra RD; Onken MD BMC Med Genomics; 2018 Nov; 11(1):97. PubMed ID: 30400891 [TBL] [Abstract][Full Text] [Related]
10. Estimation of the timing of BAP1 mutation in uveal melanoma progression. Uner OE; See TRO; Szalai E; Grossniklaus HE; Stålhammar G Sci Rep; 2021 Apr; 11(1):8923. PubMed ID: 33903674 [TBL] [Abstract][Full Text] [Related]
11. Slow proliferation of BAP1-deficient uveal melanoma cells is associated with reduced S6 signaling and resistance to nutrient stress. Chua V; Lopez-Anton M; Mizue Terai ; Ryota Tanaka ; Baqai U; Purwin TJ; Haj JI; Waltrich FJ; Trachtenberg I; Luo K; Tudi R; Jeon A; Han A; Chervoneva I; Davies MA; Aguirre-Ghiso JA; Sato T; Aplin AE Sci Signal; 2024 Jun; 17(840):eadn8376. PubMed ID: 38861613 [TBL] [Abstract][Full Text] [Related]
12. BAP1 Loss Is Associated with DNA Methylomic Repatterning in Highly Aggressive Class 2 Uveal Melanomas. Field MG; Kuznetsov JN; Bussies PL; Cai LZ; Alawa KA; Decatur CL; Kurtenbach S; Harbour JW Clin Cancer Res; 2019 Sep; 25(18):5663-5673. PubMed ID: 31285370 [TBL] [Abstract][Full Text] [Related]
13. Correlation of Immunocytochemistry of BRCA1-associated Protein-1 (BAP1) With Other Prognostic Markers in Uveal Melanoma. Glasgow BJ; McCannel TA Am J Ophthalmol; 2018 May; 189():122-126. PubMed ID: 29530782 [TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma. Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874 [TBL] [Abstract][Full Text] [Related]
15. Germline large deletion of BAP1 and decreased expression in non-tumor choroid in uveal melanoma patients with high risk for inherited cancer. Boru G; Grosel TW; Pilarski R; Stautberg M; Massengill JB; Jeter J; Singh A; Marino MJ; McElroy JP; Davidorf FH; Cebulla CM; Abdel-Rahman MH Genes Chromosomes Cancer; 2019 Sep; 58(9):650-656. PubMed ID: 30883995 [TBL] [Abstract][Full Text] [Related]
16. BAP1 germline mutation in two first grade family members with uveal melanoma. Maerker DA; Zeschnigk M; Nelles J; Lohmann DR; Worm K; Bosserhoff AK; Krupar R; Jägle H Br J Ophthalmol; 2014 Feb; 98(2):224-7. PubMed ID: 24187051 [TBL] [Abstract][Full Text] [Related]
17. BAP1 protein loss by immunohistochemistry: a potentially useful tool for prognostic prediction in patients with uveal melanoma. Shah AA; Bourne TD; Murali R Pathology; 2013 Dec; 45(7):651-6. PubMed ID: 24247622 [TBL] [Abstract][Full Text] [Related]
18. Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development. Figueiredo CR; Kalirai H; Sacco JJ; Azevedo RA; Duckworth A; Slupsky JR; Coulson JM; Coupland SE J Pathol; 2020 Apr; 250(4):420-439. PubMed ID: 31960425 [TBL] [Abstract][Full Text] [Related]